Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
Oguntibeju, O. O. (2019) · Europe PMC (PubMed Central) · Cited by 1,224
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Self-citationVEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
“Accordingly, the review begins by introducing the current biology of the VEGFR1 itself and in context with VEGFR2, Abbreviations AMD Age-related macular degeneration BRB Blood–retina barrier BRVO Branch retinal vein occlusion CCL2 CC chemokine ligand 2 CNV Choroidal neovascularization CRVO Central retinal vein occlusi…”
ResultInfluentialDiabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 300
“background inflammation, is maintained by cytokines such as IL-6, IL-8 and monocyte chemoattractant protein-1 (MCP-1, also known as the C-C motif chemokine ligand 2 (CCL2)) [18,59].”
BackgroundInfluentialJoussen, A. M., Ricci, F., Paris, L. P., Korn, C., Quezada-Ruiz, C., & Zarbin, M. (2021) · Eye · doi:10.1038/s41433-020-01377-x · Cited by 290
Xu, G.-T., Zhang, J.-F., & Tang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.355743 · Cited by 280
“…et al., 2018), as pro-inflammatory mediators, adhesion molecules, chemokines, and growth factors (Altmann and Schmidt, 2018; Lu et al., 2018; Rübsam et al., 2018; Wang and Lo, 2018; Whitehead et al., 2018), are increased and extensively involved in the pathogenesis of DR. Inflammatory cells…”
BackgroundInfluentialPathophysiology of diabetic retinopathy: The old and the new
Kusuhara, S., Fukushima, Y., Ogura, S., Inoue, N., & Uemura, A. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0182 · Cited by 250
“To date, several compounds and antibody drugs that target inflammatory signals, such as MCP-1, TNF-α, IL-1β, and IL-6, have been evaluated clinically for DME or DR [19,40], but none of them has been approved.”
BackgroundOxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies
Rodríguez, M. L., Pérez, S., Mena-Mollá, S., Desco, M. C., & Ortega, Á. L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4940825 · Cited by 222
“For this reason, the use of intravitreal corticosteroids in clinical practice is currently reserved as a second-line treatment in patients with previous cataract surgery [49].”
BackgroundInfluentialLipoprotein‐associated phospholipase A2: The story continues
Huang, F., Wang, K., & Shen, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21597 · Cited by 212
“nonproliferative stage (NPDR), characterized by microaneurysms, retinal hemorrhages, vascular tortuosity, and hard exudates; and a proliferative stage (PDR), characterized by the creation of new but leaky blood vessels.(188) In addition,”
BackgroundYue, T., Shi, Y., Luo, S., Weng, J., Wu, Y., & Zheng, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1055087 · Cited by 208
“As a result of the long-term release of inflammatory factors in the tissue, these white blood cells continue to exude from the blood vessels and eventually accumulate in the tissue (28).”
BackgroundEndothelial Dysfunction in Diabetic Retinopathy
Gui, F., You, Z., Fu, S., Wu, H., & Zhang, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00591 · Cited by 207
Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
Semeraro, F., Morescalchi, F., Cancarini, A., Russo, A., Rezzola, S., & Costagliola, C. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.04.002 · Cited by 205
Classification of diabetic retinopathy: Past, present and future
Yang, Z., Tan, T.-E., Shao, Y., Wong, T. Y., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1079217 · Cited by 201
Kong, H., Zhao, H., Chen, T., Song, Y., & Cui, Y. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04786-w · Cited by 180
“Hyperglycemia and inflammation are the main factors affecting DR pathophysiology [5, 6].”
Inflammatory and angiogenic biomarkers in diabetic retinopathy
Kaštelan, S., Orešković, I., Bišćan, F., Kaštelan, H., & Gverović Antunica, A. (2020) · Biochemia medica · doi:10.11613/bm.2020.030502 · Cited by 178
“Extensive research has verified the role of inflammation and angiogenesis in the pathogenesis of DR (4,5,6,9-15,18).”
BackgroundMethodInfluentialHeat Shock Proteins Regulatory Role in Neurodevelopment
Miller, D. J., & Fort, P. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00821 · Cited by 175
“Several Hsps, including HspB1, αA- and αB-crystallin, and Hsp90α, have since been shown to be secreted in exosomes or plasma membranederived vesicles (Graner et al., 2007; Wang et al., 2009; Sreekumar et al., 2010; Nafar et al., 2015; Barreca et al., 2017; Ruebsam et al., 2018).”
InfluentialSelf-citationThe role of inflammation in diabetic eye disease
Mesquida, M., Drawnel, F., & Fauser, S. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00750-7 · Cited by 170
Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients
Mrugacz, M., Bryl, A., & Zorena, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030458 · Cited by 172
“Under the diabetic environment, characterized by dysmetabolic and hypoxic, astrocytes are activated and produce a variety of pro-inflammatory cytokines as well as chemokines, together with T-cells, monocytes/macrophages, and microglia, amplifying the inflammatory response [71].”
BackgroundThe mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
Zheng, X., Wan, J., & Tan, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151185 · Cited by 184
Sinclair, S. H., & Schwartz, S. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00843 · Cited by 170
“Furthermore, imbalance in levels of native neuroprotective factors in the retina such as somatostatin, insulin, PEDF, and ciliary neurotrophic factor (CNTF) can also be corrected by supplementation (61, 113–115).”
BackgroundInfluentialPericytes in Microvessels: From “Mural” Function to Brain and Retina Regeneration
Caporarello, N., D’Angeli, F., Cambria, M. T., Candido, S., Giallongo, C., Salmeri, M., Lombardo, C., Longo, A., Giurdanella, G., Anfuso, C. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246351 · Cited by 142
Quercetin: an effective polyphenol in alleviating diabetes and diabetic complications
Yan, L., Vaghari‐Tabari, M., Malakoti, F., Moein, S., Qujeq, D., Yousefi, B., & Asemi, Z. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2067825 · Cited by 155
“…1), VCAM1 (vascular cell adhesion molecule), NF-kB, and PTEN are accompanied by diabetic retinopathy progression (Khalfaoui, Lizard, and Ouertani-Meddeb 2008; Choudhuri et al. 2015; Lin et al. 2016; Tien et al. 2017; Rübsam, Parikh, and Fort 2018; Yao, Du, et al. 2019; ValdezGuerrero et al. 2021).”
BackgroundAlzheimer’s Retinopathy: Seeing Disease in the Eyes
Mirzaei, N., Shi, H., Oviatt, M., Doustar, J., Rentsendorj, A., Fuchs, D.-T., Sheyn, J., Black, K. L., Koronyo, Y., & Koronyo-Hamaoui, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00921 · Cited by 128
Gu, C., Draga, D., Zhou, C., Su, T., Zou, C., Gu, Q., Lahm, T., Zheng, Z. J., & Qiu, Q. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27825 · Cited by 131
The innate immune system in diabetic retinopathy
Pan, W. W., Lin, F., & Fort, P. E. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100940 · Cited by 125
Self-citationCarpi-Santos, R., Reis, R. A. D. M., Gomes, F. C. A., & Calaza, K. D. C. (2022) · Antioxidants · doi:10.3390/antiox11040617 · Cited by 138
The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy
Min, J., Zeng, T., Roux, M., Lazar, D., Chen, L., & Tudzarova, S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab362 · Cited by 132
“Although some types of stress, such as ischemic/hypoxic stress, will increase PFKFB3-driven glycolysis in astrocytes, at the same time, it is proposed that it leads to the secretion of proinflammation factors that compromise the BRB integrity (157).”
BackgroundTu, Y., Song, E., Wang, Z., Ji, N., Zhu, L., Wang, K., Sun, H., Zhang, Y., Zhu, Q., Liu, X., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111274 · Cited by 126
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Peplow, P., & Martinez, B. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.259602 · Cited by 121
“Recent studies have indicated that DR is an inflammatory disease, with oxidative stress, formation of advanced glycation end-products and increased expression of VEGF all contributing to the inflammatory response (Semeraro et al., 2015; Rubsam et al., 2018).”
BackgroundPericytes, inflammation, and diabetic retinopathy
Spencer, B. G., Estevez, J. J., Liu, E., Craig, J. E., & Finnie, J. W. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00647-9 · Cited by 121
“Retinal neurodegeneration occurs early in DR with neuronal apoptosis, retinal ganglion cells being damaged initially, followed by outer nuclear layer neurons and associated photoreceptors (Barber et al. 2011; Rubsam et al. 2018).”
BackgroundInfluentialHove, I. V., Groef, L. D., Boeckx, B., Modave, E., Hu, T., Beets, K., Etienne, I., Bergen, T. V., Lambrechts, D., Moons, L., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05218-0 · Cited by 118
“It has become clear that diabetic retinopathy comprises neurodegenerative [4, 5] and neuroinflammatory [6, 7] disease components, with glial, neuronal and endothelial dysfunction being interdependent and essential for disease development.”
BackgroundVujosevic, S., Parra, M. M., Hartnett, M. E., O’Toole, L., Nuzzi, A., Limoli, C., Villani, E., & Nucci, P. (2022) · Eye · doi:10.1038/s41433-022-02056-9 · Cited by 119
“Diabetes Mellitus In DM, chronic hyperglycaemia leads to an early damage of the neurovascular unit with consequent neurodegeneration and reactive gliosis, neuro-inflammation, microvascular damage and RPE and choroid pathology [50, 51].”
BackgroundFeng, L., Liang, L., Zhang, S., Yang, J., Yue, Y., & Zhang, X. (2021) · Autophagy · doi:10.1080/15548627.2021.1926655 · Cited by 108
“Previous studies have reported that HG treatment can induce early signs of DR, including mitochondrial dysfunction, cytokine release, and apoptosis of RPE cells [2,3].”
BackgroundUpdates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy
Tomita, Y., Lee, D., Tsubota, K., Negishi, K., & Kurihara, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204666 · Cited by 123
“Many experimental studies showed that increases in these cytokines and chemokines contributed to cell death of retinal neurons in DR [41,42].”
BackgroundDiabetic retinopathy: Involved cells, biomarkers, and treatments
Ren, J., Zhang, S., Pan, Y., Jin, M., Li, J., Luo, Y., Sun, X., & Li, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.953691 · Cited by 110
“Glial cells are supporting cells of the neural retina and play an important role in the immune system of the retina (Rubsam et al., 2018).”
BackgroundSergeys, J., Etienne, I., Hove, I. V., Lefevere, E., Stalmans, I., Feyen, J. H. M., Moons, L., & Bergen, T. V. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25372 · Cited by 106
Cross Talks between Oxidative Stress, Inflammation and Epigenetics in Diabetic Retinopathy
Kowluru, R. A. (2023) · Cells · doi:10.3390/cells12020300 · Cited by 112
“In addition, NF-kB regulates the activation of inflammasomes, and recent studies have shown that the inflammatory cascade is initiated in the glial cells [35], inflammatory cytokines in a hyperglycemic environment activate resi-”
BackgroundThe cells involved in the pathological process of diabetic retinopathy
Yang, S., Zhang, J., & Chen, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110818 · Cited by 93
Cheng, Y., Yu, X., Zhang, J., Chang, Y., Xue, M., Li, X., Lu, Y., Li, T., Meng, Z., Su, L., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4838-9 · Cited by 84
Inflammation and retinal degenerative diseases
Kaur, G., & Singh, N. K. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.350192 · Cited by 100
The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy—A Short Review
Gomułka, K., & Ruta, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021024 · Cited by 108
Albert-Garay, J. S., Riesgo‐Escovar, J. R., & Salceda, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-05284-x · Cited by 93
Lv, P., Yu, J., Xu, X., Lu, T., & Xu, F. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27848 · Cited by 79
“In addition, ROS is considered as a strong stimulus for the release of some proinflammatory cytokines, which play a major role in the activation of subsequent inflammatory responses.(17) Taken together, oxidative stress and inflammation are considered as critical contributors to the development of DR.”
BackgroundA Review on Mesenchymal Stem Cells for Treatment of Retinal Diseases
Adak, S., Magdalene, D., Deshmukh, S., Das, D., & Jaganathan, B. G. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10090-x · Cited by 86
“Activation of retinal glial cells including astrocytes, mϋller cells and microglia play a significant role in the onset of inflammation at the later stages of DR [99].”
BackgroundQuercetin protects against diabetic retinopathy in rats by inducing heme oxygenase-1 expression
Chen, X., Chai, G., Liu, S. Q., & Yang, H. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.301027 · Cited by 76
“Because inflammation is an important part of the pathogenesis of DR (Rübsam et al., 2018), the influence of quercetin on pro-inflammatory factors was investigated to clarify the mechanisms underlying the retinal protection provided by the flavonoid.”
Innovative Hydrogel Design: Tailoring Immunomodulation for Optimal Chronic Wound Recovery
Lai, C., Chen, W., Yuan, Q., Xu, D., Lai, Y., & He, S. (2024) · Advanced Science · doi:10.1002/advs.202412360 · Cited by 94
Wang, J.-R., Chen, Z., Yang, K., Yang, H.-J., Tao, W.-Y., Li, Y.-P., Jiang, Z.-J., Bai, C.-F., Yin, Y.-C., Duan, J.-M., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00562-y · Cited by 74
Reddy, S. K., Abhijna Ballal, R., Shailaja, S., Seetharam, R. N., Hariharapura, R. C., Sankhe, R., Pai, K., Tender, T., Mathew, M., Aroor, A. R., et al. (2023) · Theranostics · doi:10.7150/thno.78426 · Cited by 77
“Previous studies have demonstrated that retinal inflammation is directly linked with DR [52, 53].”
BackgroundOcular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology · doi:10.2147/opth.s364200 · Cited by 76
Interleukin-6 and Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Yao, Y., Li, R., Du, J., Long, L., Li, X., & Luo, N. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1570274 · Cited by 72
“First, IL-6 serves as a major driving force that leads to the overall cytokine profile change in the aqueous humor of DR patients and involves in the inflammatory response.(10) For example, Koleva-Georgieva et al.”
BackgroundThe Benefits of Flavonoids in Diabetic Retinopathy
Matos, A. L., Bruno, D. F., Ambrósio, A. F., & Santos, P. F. (2020) · Nutrients · doi:10.3390/nu12103169 · Cited by 71
“Although in the retina these proinflammatory cytokines can be released by various cell types, such as endothelial cells, macroglial cells or even neurons [35–37], microglia and infiltrant monocytes are their principal producers in diabetic retinas [27].”
BackgroundDiabetic Retinopathy: Role of Neurodegeneration and Therapeutic Perspectives
Simó, R., Simó‐Servat, O., Bogdanov, P. M., & Hernández, C. (2022) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000510 · Cited by 85
Shi, Q., Wang, Q., Wang, Z., Lu, J., & Wang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1088778 · Cited by 86
“In response to these injury, some retinal cell types, such as astrocytes and neurons, can upregulate the expression of various gene encoding cytokines, chemokines and elements of the complement cascade, promoting retinal degeneration (53).”
BackgroundPyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy
Meng, C., Gu, C., He, S., Su, T., Lhamo, T., Draga, D., & Qiu, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763092 · Cited by 78
“Researchers found increased levels of proinflammatory mediators in the serum or aqueous humor in patients with DR compared with normal controls (20).”
BackgroundAi, X., Yu, P., Hou, Y., Song, X.-C., Luo, J., Li, N., Lai, X., Wang, X., & Meng, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110852 · Cited by 81
Nouri, Z., Hajialyani, M., Izadi, Z., Bahramsoltani, R., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00425 · Cited by 73
“Diabetic retinopathy is considered as a common complication of diabetes which caused visual dimming and blindness (Rübsam et al., 2018).”
BackgroundWooff, Y., Cioanca, A. V., Chu‐Tan, J. A., Aggio‐Bruce, R., Schümann, U., & Natoli, R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00160 · Cited by 72
The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases
Busscher, D., Boon, R. A., & Juni, R. P. (2022) · Clinical Science · doi:10.1042/cs20210994 · Cited by 68
Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target
Peng, J.-J., Xiong, S.-Q., Ding, L., Peng, J., & Xia, X. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.038 · Cited by 71
Putative Biomarkers in Tears for Diabetic Retinopathy Diagnosis
Amorim, M., Martins, B. D., Caramelo, F. J., Gonçalves, C., Trindade, G., Simão, J., Barreto, P., Marques, I. P., Leal, E. C., Carvalho, E., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.873483 · Cited by 74
“Previous reports demonstrated the presence of Th1 and Th2 cytokines in vitreous samples (74).”
BackgroundOcular Vascular Diseases: From Retinal Immune Privilege to Inflammation
Wang, X., Wang, T., Lam, E., Álvarez, D., & Sun, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512090 · Cited by 76
Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2019.117152 · Cited by 63
Robles-Rivera, R. R., Castellanos‐González, J. A., Olvera-Montaño, C., Flores-Martin, R. A., López-Contreras, A. K., Arévalo-Simental, D. E., Cardona-Muñóz, E. G., Román-Pintos, L. M., & Rodríguez-Carrizález, A. D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3096470 · Cited by 71
“Inflammation correlates with an increased concentration in PDR over early stages [13].”
BackgroundComplement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
Mandava, N., Tirado, V., Geiger, M. D., Patnaik, J. L., Frazer‐Abel, A. A., Lynch, A. M., Mandava, N., Palestine, A. G., Holers, V. M., Wagner, B. D., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.11.39 · Cited by 63
“C5 (ng/mL) 46,987 (11,441)/45,938 41,050 (11,950)/38,429 0.”
The role of retinal Müller cells in diabetic retinopathy and related therapeutic advances
Yang, S., Qi, S., & Wang, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1047487 · Cited by 62
“When bound to their ligands, these receptors could activate the mitogen-activated protein kinase (MAPK) signaling pathway, thereby upregulating the expression of proinflammatory cytokines (Rübsam et al., 2018).”
BackgroundKulkarni, A. A., Thool, A. R., & Daigavane, S. V. (2024) · Cureus · doi:10.7759/cureus.56674 · Cited by 117
Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach
Potilinski, M. C., Lorenc, V. E., Perisset, S., & Gallo, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072351 · Cited by 66
Yapislar, H., & Gurler, E. B. (2024) · Biomedicines · doi:10.3390/biomedicines12091958 · Cited by 64
“…features the activation of inflammatory pathways and metabolic abnormalities such as the polyol pathway, the hexosamine biosynthetic pathway, the protein kinase C pathway, and the accumulation of AGEs, which contribute to increased oxidative stress and inflammation within the retina [50–52].”
BackgroundFang, M., Wan, W., Li, Q., Wan, W., Long, Y., Liu, H., & Yang, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119567 · Cited by 60
Singer, M. A., Sheth, V. S., Mansour, S. E., Coughlin, B., & González, V. H. (2022) · Ophthalmology · doi:10.1016/j.ophtha.2022.01.015 · Cited by 60
NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy
Lim, R. R., Wieser, M. E., Ganga, R., Barathi, V. A., Lakshminarayanan, R., Mohan, R. R., Hainsworth, D. P., & Chaurasia, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030899 · Cited by 61
“Chronic inflammation plays a central role in DR pathology [1,2].”
BackgroundInfluentialOxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy
Rossino, M. G., Lulli, M., Amato, R., Cammalleri, M., Monte, M. D., & Casini, G. (2020) · Cells · doi:10.3390/cells9061452 · Cited by 59
“For instance, it is known that inflammatory cytokines may promote VEGF expression [45].”
Canonica, J., Foxton, R. H., Garrido, M. G., Lin, C., Uhles, S., Shanmugam, S., Antonetti, D. A., Abcouwer, S. F., & Westenskow, P. D. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1192464 · Cited by 63
“Further, the multi-factorial etiology of these diseases suggests that targeting additional pathways besides VEGF may facilitate greater vascular stability and prolonged disease remission, potentially contributing to increased treatment efficacy and durability compared with intravitreal anti-VEGF monotherapy (Grossnikl…”
BackgroundDănilă, A.-I., Ghenciu, L. A., Stoicescu, E. R., Bolintineanu, S. L., Iacob, R., Săndesc, M. A., & Faur, A. C. (2024) · Biomedicines · doi:10.3390/biomedicines12040747 · Cited by 69
“These pathways, in conjunction with genetic risk factors, ultimately lead to the activation of growth factors, cytokines and chemokines, which in consequence cause increased vascular permeability, microvascular occlusion, and malfunction of the vascular endothelium [18,25–27].”
BackgroundThe potential role of m6A RNA methylation in diabetic retinopathy
Kumari, N., Karmakar, A., Khan, M. M. A., & Ganesan, S. K. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108616 · Cited by 62
The neutrophil percentage‐to‐albumin ratio is related to the occurrence of diabetic retinopathy
He, X., Dai, F., Zhang, X., & Pan, J. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24334 · Cited by 57
Lv, K., Ying, H., Hu, G., Hu, J., Jian, Q., & Zhang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.942768 · Cited by 63
“Early retinal inflammatory processes are now well established to play a central role in the pathogenesis of DR (10).”
BackgroundOuyang, H., Mei, X., Zhang, T., Lü, B., & Ji, L. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.09.027 · Cited by 62
The Metaflammatory and Immunometabolic Role of Macrophages and Microglia in Diabetic Retinopathy
Wu, H.-L., Wang, M., Li, X., & Shao, Y. X. (2021) · Human Cell · doi:10.1007/s13577-021-00580-6 · Cited by 56
“were elevated in the vitreous or aqueous humor of diabetic patients, accompanying with microglia activation which was found to play an important part in the pathophysiological process of DR [4, 5].”
BackgroundWang, N., Zhang, C., Xu, Y., Tan, H., Chen, H., & Feng, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62868 · Cited by 54
“Crosstalk between the two pathogenic signs of progress has been extensively discussed [35].”
BackgroundJin, Z., Zhang, Q., Liu, K., Wang, S., Yan, Y., Zhang, B., Zhao, L., & Tong, X. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111615 · Cited by 68
Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
Wu, H., Norton, V., Cui, K., Zhu, B., Bhattacharjee, S., Lu, Y. W., Wang, B., Shan, D., Wong, S., Dong, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841928 · Cited by 72
Jiang, M., Xie, H., Zhang, C., Wang, T., Tian, H., Lü, L., Xu, J., Xu, G., Liu, L., & Zhang, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17179 · Cited by 53
Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers
Parravano, M., Cennamo, G., Antonio, L. D., Grassi, M. O., Lupidi, M., Rispoli, M., Savastano, M. C., Veritti, D., & Vujosevic, S. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.06.006 · Cited by 63
Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy
Narayanan, S. P., Shosha, E., & Palani, C. D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104299 · Cited by 58
Wang, H., Guo, Z., & Xu, Y. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03425-4 · Cited by 52
“These chemokines play major roles in the recruitment and activation of monocytes and leukocytes and the subsequent inflammatory responses in patients with DR [10, 20].”
BackgroundRole of toll-like receptor 4 in diabetic retinopathy
Bayan, N., Yazdanpanah, N., & Rezaei, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105960 · Cited by 55
The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus
Zeng, J., Chen, M., Qiu, F., Wan, H., Wang, J., Yang, F., & Cao, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s378284 · Cited by 60
“42 Hatori et al discovered that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as sulindac would be effective in preventing the progression of mild DR. 43 There is growing evidence that inflammation plays a significant role in the onset and progression of DR. 11 Numerous…”
Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy
Pfeifer, C. W., Walsh, J. T., Santeford, A. C., Lin, J. B., Beatty, W. L., Terao, R., Liu, Y. A., Hase, K., Ruzycki, P. A., & Apte, R. S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308214120 · Cited by 55
Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration
Vujosevic, S., Lupidi, M., Donati, S., Astarita, C., Gallinaro, V., & Pilotto, E. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.07.006 · Cited by 54
Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications
Solini, A., & Novak, I. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.009 · Cited by 51
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
Muniyandi, A., Hartman, G. D., Song, Y., Mijit, M., Kelley, M. R., & Corson, T. W. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001563 · Cited by 54
“In DR, hyperglycemia initially leads to vascular dysfunction; in fl ammation characterized by gliosis, microglial activation, and edema (R € ubsam et al., 2018); and ischemic areas.”
BackgroundSubclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes
Herder, C., & Hermanns, N. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00730-x · Cited by 52
Maisto, R., Trotta, M. C., Petrillo, F., Izzo, S., Cuomo, G., Alfano, R., Hermenean, A. O., Barcia, J. M., Galdiero, M., Platania, C. B. M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00235 · Cited by 49
“Diabetic retinopathy (DR) has been regarded as a vascular disorder for many years, even inflammation has gained a central role in the pathophysiology of the disease (Rübsam et al., 2018).”
BackgroundCoulter‐Parkhill, A., McClean, S., Gault, V. A., & Irwin, N. (2021) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514211006071 · Cited by 55
Zhou, Z., Ju, H., Sun, M., & Chen, H. (2019) · Disease Markers · doi:10.1155/2019/9401628 · Cited by 54
“Second, increasing evidence indicates inflammation is a key player in the development of DR [55] and VEGF is a strong inducer of inflammation [56].”
BackgroundRetinal microglia polarization in diabetic retinopathy
Li, X., Yu, Z.-W., Li, H.-Y., Yuan, Y., Gao, X., & Kuang, H. (2021) · Visual Neuroscience · doi:10.1017/s0952523821000031 · Cited by 51
“Especially, retinal ganglion cells (RGCs) death and retinal microglial cells (RMC) activation are regarded as two early features in DR (Rübsam et al., 2018).”
BackgroundThe role of inflammation and neurodegeneration in diabetic macular edema
Starace, V., Battista, M., Brambati, M., Cavalleri, M., Bertuzzi, F., Amato, A., Lattanzio, R., Bandello, F. M., & Cicinelli, M. V. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211055963 · Cited by 61
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.